These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1297403)

  • 21. Optimal antibiotic therapy in bronchopulmonary infections.
    Neu HC
    Infection; 1980; Suppl 1():62-9. PubMed ID: 7399717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Some features of the side effects of antibiotics in bronchopulmonary diseases].
    Zamotaev IP; Khvoĭnitskaia IL; Nonikov VE; Sokolova VI
    Antibiotiki; 1977 Sep; 22(9):794-7. PubMed ID: 911152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Application of antibiotics in vulnerable groups].
    Turkulov V; Brkić S; Doder R; Vukadinov J; Sević S; Canak G
    Med Pregl; 2010; 63 Suppl 1():33-6. PubMed ID: 21438202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respiratory tract infections in the immunocompromised.
    Godbole G; Gant V
    Curr Opin Pulm Med; 2013 May; 19(3):244-50. PubMed ID: 23508112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Empiric therapy of severe infections in adults.
    Modai J
    Am J Med; 1990 Apr; 88(4A):12S-17S. PubMed ID: 2183604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pneumonia. Patient profiles, choice of empiric therapy, and the place of third-generation cephalosporins.
    Leedom JM
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):57-65. PubMed ID: 1730186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pneumonia in the immune compromised host].
    Flückiger U; Trampuz A
    Ther Umsch; 2001 Oct; 58(10):614-9. PubMed ID: 11695093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Early results of treatment of bacterial infections in chronic bronchial diseases].
    Sosnowski W; Ratajek M; Krawczyk Z; Lewandowska A
    Gruzlica; 1975 Jan; 43(1):29-35. PubMed ID: 1110037
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antibiotic strategy in bronchial infections. Role of roxithromycin].
    Gaillat J
    Presse Med; 1997 Mar; 26 Suppl 2():16-21. PubMed ID: 9113048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The 14th National Conference of Pneumophthisiology. Round table: the chemotherapy of bronchopulmonary suppurations].
    Bercea O; Bittner J; Căruntu F; Chiotan D; Diaconescu C; Galbenu P; Mihălţan F; Nicolaescu O; Popescu C; Stoicescu P
    Pneumoftiziologia; 1992; 41(2-3):159-72. PubMed ID: 1364160
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinico-pharmacologic aspects of the use of ofloxacin].
    Kukes VG; Belitskaia RA; Dubova MN; Krasavina MIu; Posrednikova TA
    Antibiot Khimioter; 1996; 41(9):39-42. PubMed ID: 9005783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current treatment of primary bronchopulmonary suppurations].
    Ionescu C
    Rev Med Chir Soc Med Nat Iasi; 1972; 16(3):753-8. PubMed ID: 5080571
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of rifamethoprim in acute and chronic respiratory tract diseases].
    Orlov VA; Sokolova VI; Troshina EV; Manuĭlov KK; Pozdniakova VP; Berezovskaia LN
    Antibiot Khimioter; 1992 Jan; 37(1):42-4. PubMed ID: 1530359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary infections in immunocompromised hosts: the importance of correlating the conventional radiologic appearance with the clinical setting.
    Oh YW; Effmann EL; Godwin JD
    Radiology; 2000 Dec; 217(3):647-56. PubMed ID: 11110924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Problems of pharmacotherapy of infections in the aged].
    Kuhnke A; Lode H
    Internist (Berl); 2003 Aug; 44(8):986-94. PubMed ID: 14671813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Etiology of pneumonia and host defense].
    Sato A; Okano A
    Kansenshogaku Zasshi; 1992 Sep; 66(9):1276-82. PubMed ID: 1431388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative effectiveness of immunomodulators in the therapy of bronchopulmonary diseases].
    Zemskov AM; Provotorov VM; Nikitin AV; Zemskov VM
    Antibiotiki; 1984 Sep; 29(9):673-6. PubMed ID: 6508258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Principles of antibiotic therapy in pulmonology].
    Ukhin AV
    Antibiot Khimioter; 1992 May; 37(5):46-51. PubMed ID: 1417332
    [No Abstract]   [Full Text] [Related]  

  • 39. Empiric therapy for the immunocompromised host.
    Armstrong D
    Rev Infect Dis; 1991; 13 Suppl 9():S763-9. PubMed ID: 1925322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of pleural and sputum concentrations for antibiotic therapy of bronchopulmonary infections.
    Lode H; Gruhlke G; Hallermann W; Dzwillo G
    Infection; 1980; Suppl 1():49-53. PubMed ID: 7399714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.